Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?

Carlotta GiupponiDiego BertoliErika BorlenghiChiara CattaneoTatiana ZollnerLorenzo MasinaSamuele BagnascoElisa CerquiFrancesca FedericoChiara PaganiSilvana ArchettiDuilio BrugnoniGiuseppe RossiAlessandra Tucci

Published in: Blood cancer journal (2023)

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
risk assessment
low grade
disease activity
free survival
rheumatoid arthritis
dendritic cells
wild type
acute lymphoblastic leukemia